Skip to main content
. 2008 Oct 8;2(1):75–79. doi: 10.1111/j.1752-8062.2008.00052.x

Figure 2.

Figure 2

Comparison of tumor cell lines and primary tumor cells as fusion partners. Groups of 10 mice were immunized with 5.0 × 105 electrofused cells on days 0 and 14. A lethal subcutaneous tumor challenge with M3 tumor cells was performed on day 21. Tumor size was measured twice a week. Immunization with either of the electrofusion vaccines resulted in a statistically significant increase in survival compared to vehicle‐treated mice (p < 0.0001).